Fifth Third Bancorp’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Fifth Third Bancorp’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-736	Closed	-$17K	–	2561
2021 Q1	$17K	Hold	736	–	–	﹤0.01%	1842
2020 Q4	$18K	Sell	736 -162	-18%	-$5.37K	﹤0.01%	1753
2020 Q3	$37K	Sell	898 -75	-8%	-$3.45K	﹤0.01%	1424
2020 Q2	$47K	Sell	973 -125	-11%	-$9.66K	﹤0.01%	1332
2020 Q1	$69K	Sell	1,098 -40	-4%	-$3.6K	﹤0.01%	1175
2019 Q4	$141K	Buy	1,138 +402	+55%	+$36K	﹤0.01%	1045
2019 Q3	$49K	Hold	736	–	–	﹤0.01%	1368
2019 Q2	$59K	Hold	736	–	–	﹤0.01%	1298
2019 Q1	$82K	Hold	736	–	–	﹤0.01%	1127
2018 Q4	$74K	Hold	736	–	–	﹤0.01%	1125
2018 Q3	$93K	Hold	736	–	–	﹤0.01%	1113
2018 Q2	$62K	Hold	736	–	–	﹤0.01%	1243
2018 Q1	$45K	Hold	736	–	–	﹤0.01%	1378
2017 Q4	$43K	Sell	736 -1,426	-66%	-$89.9K	﹤0.01%	1322
2017 Q3	$125K	Buy	2,162 +1,200	+125%	+$129K	﹤0.01%	1002
2017 Q2	$116K	Hold	962	–	–	﹤0.01%	1024
2017 Q1	$109K	Sell	962 -196	-17%	-$22.9K	﹤0.01%	1063
2016 Q4	$126K	Buy	1,158 +960	+485%	+$114K	﹤0.01%	1037
2016 Q3	$33K	Buy	+198	New	+$31.2K	﹤0.01%	1460
2016 Q2	–	Sell	-9	Closed	-$1K	–	2368
2016 Q1	$1K	Sell	9 -551	-98%	-$65.1K	﹤0.01%	2272
2015 Q4	$84K	Sell	560 -22	-4%	-$3.72K	﹤0.01%	1204
2015 Q3	$97K	Sell	582 -27	-4%	-$5.94K	﹤0.01%	1164
2015 Q2	$147K	Buy	609 +95	+18%	+$25.3K	﹤0.01%	1072
2015 Q1	$145K	Sell	514 -181	-26%	-$39.2K	﹤0.01%	1079
2014 Q4	$108K	Buy	695 +218	+46%	+$40.3K	﹤0.01%	1137
2014 Q3	$113K	Buy	477 +149	+45%	+$38K	﹤0.01%	1132
2014 Q2	$78K	Buy	328 +106	+48%	+$27.9K	﹤0.01%	1260
2014 Q1	$73K	Sell	222 -389	-64%	-$131K	﹤0.01%	1271
2013 Q4	$42K	Buy	+611	New	+$35.3K	﹤0.01%	1404

Other funds holding ICPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Fifth Third Bancorp's ICPT Position: Q2 2021 in Review

Fifth Third Bancorp sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2021, closing a stake of 736 shares — an estimated $17K sold.

Fifth Third Bancorp first reported a position in ICPT in Q4 2013 and held it in 29 quarters. The position peaked at $147K in Q2 2015. 129 funds tracked by Wall St. Rank hold ICPT as of Q2 2021.

Fifth Third Bancorp reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
Fifth Third Bancorp sold 736 Intercept Pharmaceuticals, Inc. shares in Q2 2021, an estimated $17K.
Fifth Third Bancorp first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2013 and held it in 29 quarters.
Fifth Third Bancorp's Intercept Pharmaceuticals, Inc. position peaked at $147K in Q2 2015.
129 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2021.

Based on Fifth Third Bancorp's 13F filing for Q2 2021, filed 6 Aug 2021.